About Us

Biography - Michael Mancino, MD, FASAM

MancinoMichael-wwwDr. Mancino graduated medical school from Northeastern Ohio Universities College of Medicine. He trained for several years in neurological surgery and ultimately completed his training at UAMS in psychiatry in 2004. He is board certified by the American Board of Psychiatry and Neurology as well as the American Board of Addiction Medicine. He is an associate professor at the UAMS Psychiatric Research Institute and currently the Program Director for the Center for Addiction Services and Treatment. He is also Medical Director of the Recovery Centers of Arkansas. He focuses his clinical practice on medication assisted treatment for opioid dependence and also treats patients with co-occurring psychiatric and substance use disorders. Dr. Mancino is also a researcher interested in conducting clinical trials for medications development for patients with psychostimulant and opioid addictions and is funded by the National Institute on Drug Abuse (NIDA) on two studies, the first as PI and the second as Co-PI with Dr. Alison Oliveto. The first study examines whether lisdexamfetamine shows promise in alleviating withdrawal symptoms and preventing relapse relative to placebo in recently-abstinent methamphetamine dependent individuals. Findings of this study will not only shed light on whether lisdexamfetamine may improve upon treatment for this disorder but also inform future medication development strategies for improving treatment for drug dependence disorders. The second study is designed to address the need for improved detoxification and antagonist maintenance strategies by assessing the efficacy and tolerability of adjunct gabapentin during buprenorphine-assisted detoxification and subsequent transition to depot naltrexone therapy in prescription opioid-dependent participants.